Phase I-Ii diaziquone chemotherapy in brain tumors
Madajewicz, S.; Spaulding, M.; Bhimani, S.; Avellanosa, A.; DeLos Santos, R.; Perry, A.; Zeigler, P.; Kirshner, J.
Cancer Treatment Reports 68(6): 913-914
1984
ISSN/ISBN: 0361-5960 PMID: 6733706 Document Number: 241352
Document emailed within 1 workday
Related Documents
Siegel, D.; Gibson, N.W.; Preusch, P.C.; Ross, D. 1990: Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells Cancer Research 50(22): 7293-7300Kuratsu, J.; Ushio, Y. 1994: Chemotherapy of brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 377-383
Edwards, M.S.; Levin, V.A.; Wilson, C.B. 1980: Brain tumor chemotherapy: an evaluation of agents in current use for phase Ii and IIi trials Cancer Treatment Reports 64(12): 1179-1205
Ushio, Y.; Mogami, H. 1987: Chemotherapy of malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3227-3233
Stieglmayr, F.S. 1973: Chemotherapy of malignant brain tumors Wiener Medizinische Wochenschrift 123(44): 637-642
Takeshima, H.; Kuratsu, J.-i. 2003: Evolution of chemotherapy for malignant brain tumors No Shinkei Geka. Neurological Surgery 31(7): 725-734
Shapiro, W.R. 1970: Further studies on chemotherapy of experimental brain tumors Neurology 20(4): 390-391
Hirose, Y. 2016: Chemotherapy for brain tumors -Present and future- Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 7): 31-36
Knerich, R.; Butti, G.; Pezzotta, S.; Robustelli della Cuna, G.; Adinolfi, D.; Pavesi, L. 1984: Chemotherapy of malignant brain tumors in childhood Minerva Medica 75(24): 1441-1444
Barjaktarević, Z.; Jeremić, B.; Sobić, V. 1989: Use of chemotherapy in brain tumors in children--possibilities and perspectives Srpski Arhiv Za Celokupno Lekarstvo 117(11-12): 837-849
Shibui, S. 2005: Resent advances in chemotherapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 442-447
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Zustovich, F.; Cartei, G.; Ceravolo, R.; Zovato, S.; Della Puppa, A.; Pastorelli, D.; Mattiazzi, M.; Bertorelle, R.; Gardiman, M.Paola. 2007: A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors Anticancer Research 27(2): 1019-1024
Seiler, R.W.; Vassella, F.; Markwalder, H. 1979: Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors Surgical Neurology 11(3): 237-242
Miyamachi, K. 1990: Chemotherapy responsiveness of brain tumors in subrenal capsule assay Hokkaido Journal of Medical Science 65(1): 41-49
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880
Hasegawa, H.; Shapiro, W.R.; Posner, J.B. 1979: Chemotherapy of experimental metastatic brain tumors in female Wistar rats Cancer Research 39(7 Part 1): 2691-2697
Aronov, M.S.; Kobiakov, G.L.; Lubnin, A.I.; Iakovlev, S.B. 2008: Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 3: 52-59
Shimura, T.; Teramoto, A.; Aihara, K. 1997: Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(6): 713-718
Tomás, R.; Haninec, P.; Houstava, L. 2006: The relevance of the corticographic median nerve somatosensory evoked potentials (SEPs) phase reversal in the surgical treatment of brain tumors in central cortex Neoplasma 53(1): 37-42